Clinical Trials on Hepatitis C (HCV) in South Africa
Total 1181 results
-
bioLytical LaboratoriesRecruiting
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Australia, Belgium, Canada, France, New Zealand, Singapore, South Africa, Vietnam
-
Kirby InstituteActive, not recruitingHepatitis C | HIV | HIV-HCV CoinfectionAustralia
-
Atea Pharmaceuticals, Inc.RecruitingHepatitis C | Hepatitis C, Chronic | HCV | Chronic Hepatitis C Virus | Hepatic CirrhosisTurkey, Brazil, Romania, Canada, Philippines, Pakistan, South Africa, Moldova, Republic of, United States, India, Korea, Republic of, Mauritius
-
Kirby InstituteMerck Sharp & Dohme LLC; The University of New South WalesCompletedChronic Hepatitis C InfectionAustralia
-
Kirby InstituteCompleted
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1Algeria, Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Greece, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, Austria, Ireland and more
-
Bristol-Myers SquibbWithdrawnChronic Hepatitis CAustralia
-
Kirby InstituteJanssen-Cilag Ltd.CompletedHepatitis C, ChronicAustralia
-
Novartis PharmaceuticalsCompletedChronic Hepatitis C Genotype-1 RelapseBelgium, United States, Germany, Spain, Puerto Rico, Taiwan, Australia
-
Kirby InstituteThe University of New South WalesCompleted
-
Garvan Institute of Medical ResearchCompleted
-
Melbourne HealthHoffmann-La Roche; Monash University; The University of New South Wales; St Vincent... and other collaboratorsCompletedChronic Hepatitis CAustralia
-
Avera McKennan Hospital & University Health CenterWithdrawnChronic Hepatitis CUnited States
-
GlaxoSmithKlineCompleted
-
Kirby InstituteCompleted
-
Kirby InstituteBristol-Myers SquibbWithdrawnHepatitis C, ChronicAustralia
-
Kirby InstituteCompletedHepatitis C, ChronicAustralia
-
Bristol-Myers SquibbCompletedHepatitis C Virus (HCV)Australia, Belgium, France, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Taiwan, United States, Chile, Hong Kong, Argentina, Netherlands, United Kingdom, Singapore, New Zealand, Finland, Greece
-
Kirby InstituteCompleted
-
Boehringer IngelheimWithdrawnHepatitis C, ChronicAustralia, Spain, Sweden
-
AbbVieActive, not recruitingHepatitis C Virus (HCV)United States, Australia, Austria, Canada, France, Germany, Italy, Spain
-
bioLytical LaboratoriesRecruitingHepatitis B | Hepatitis B InfectionSouth Africa
-
Kirby InstituteCompleted
-
Gilead SciencesCompletedChronic HCV InfectionBelgium, Austria, New Zealand, United Kingdom, Germany, Spain, Netherlands, France, Switzerland, Canada, Australia, Italy
-
Kirby InstituteAbbVieCompletedHepatitis C, AcuteUnited Kingdom, Australia, New Zealand
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France
-
Alios Biopharma Inc.Vertex Pharmaceuticals IncorporatedTerminatedHepatitis C, ChronicAustralia, New Zealand
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France, Puerto Rico
-
Bristol-Myers SquibbPharmassetCompletedChronic Hepatitis CUnited States, Puerto Rico
-
Kirby InstituteMerck Sharp & Dohme LLCCompletedHepatitis C, ChronicAustralia, Canada, United Kingdom, Belgium, Germany, Norway, Switzerland
-
Gilead SciencesTerminatedChronic Hepatitis CUnited States, Australia, Canada, New Zealand
-
Kirby InstituteUniversity of Public Health, MyanmarCompletedHIV Infections | Hepatitis C | Liver Cirrhoses | Liver InflammationAustralia
-
Sanofi Pasteur, a Sanofi CompanyCompletedHepatitis B | Pertussis | Tetanus | Diphtheria | Polio | Human Immunodeficiency Virus InfectionSouth Africa
-
University of Witwatersrand, South AfricaUnknownMeasles | Hepatitis A | VaricellaSouth Africa
-
Kirby InstituteCompletedHepatitis C, ChronicUnited States, United Kingdom, Australia, France, New Zealand, Canada, Switzerland, Germany
-
Gilead SciencesTerminatedHepatitis C Virus InfectionUnited States, United Kingdom, Australia, Germany, Italy, New Zealand, Belgium, Poland, Russian Federation
-
Bristol-Myers SquibbCompletedHepatitis CArgentina, Australia, Belgium, France, Germany, Italy, United States, Canada, Spain, Mexico, Austria, Poland, Netherlands, Korea, Republic of, Puerto Rico, New Zealand, Finland, Greece, Romania
-
Bristol-Myers SquibbCompletedChronic Hepatitis CFrance, United States, Puerto Rico
-
Human Genome Sciences Inc.NovartisCompletedChronic Hepatitis CKorea, Republic of, United States, Spain, Canada, France, Australia, Israel, Singapore, Thailand, Malaysia, Sweden, Belgium, Germany, Taiwan, Poland, Argentina, India, Puerto Rico, Brazil, Mexico, United Kingdom
-
Hologic, Inc.CompletedHepatitis CUnited States, Puerto Rico
-
Gilead SciencesCompletedChronic Hepatitis C | Human Immunodeficiency VirusFrance, Italy, United Kingdom, Germany, Spain, Australia
-
Human Genome Sciences Inc.NovartisCompletedChronic Hepatitis CUnited States, Spain, Canada, France, Australia, Italy, Israel, Poland, United Kingdom, Germany, Czech Republic, Romania, Austria, India, Puerto Rico
-
AbbVieCompletedChronic Hepatitis C VirusJapan
-
Gilead SciencesCompletedHCV InfectionUnited States, France, Australia, Puerto Rico, Spain
-
Hoffmann-La RocheCompletedHepatitis C, ChronicUnited States, New Zealand, Germany, Australia, Poland
-
Janssen Infectious Diseases BVBAVertex Pharmaceuticals IncorporatedCompletedGenotype 1 Chronic Hepatitis C | Treatment NaiveUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Spain, Sweden, Brazil, Austria, Ireland, Mexico
-
Hoffmann-La RocheCompletedHepatitis C, ChronicUnited States
-
Bausch Health Americas, Inc.CompletedChronic Hepatitis CUnited States, Spain, Italy, Australia, Canada, Poland, Puerto Rico, Russian Federation, Argentina, France, Israel, United Kingdom
-
Bristol-Myers SquibbCompletedHepatitis CAustralia, France, Germany, Italy, United Kingdom, United States, Canada, Poland, Austria, Denmark, Israel, Spain, Russian Federation, Switzerland, Argentina, Brazil